Download PDF
Thromb Haemost 2022; 122(04): 517-528
DOI: 10.1055/s-0041-1731288
Cellular Haemostasis and Platelets

Rapid Release of Interleukin-1β from Human Platelets Is Independent of NLRP3 and Caspase

Gabrielle J. Pennings
1   Vascular Biology Group, ANZAC Research Institute, Concord Repatriation General Hospital, University of Sydney, Concord, New South Wales, Australia
,
Caroline J. Reddel
1   Vascular Biology Group, ANZAC Research Institute, Concord Repatriation General Hospital, University of Sydney, Concord, New South Wales, Australia
,
Mathew Traini
1   Vascular Biology Group, ANZAC Research Institute, Concord Repatriation General Hospital, University of Sydney, Concord, New South Wales, Australia
,
Magdalena Lam
1   Vascular Biology Group, ANZAC Research Institute, Concord Repatriation General Hospital, University of Sydney, Concord, New South Wales, Australia
,
Maaike Kockx
1   Vascular Biology Group, ANZAC Research Institute, Concord Repatriation General Hospital, University of Sydney, Concord, New South Wales, Australia
,
Vivien M. Chen
1   Vascular Biology Group, ANZAC Research Institute, Concord Repatriation General Hospital, University of Sydney, Concord, New South Wales, Australia
2   Department of Haematology, Concord Repatriation General Hospital, Sydney Local Health District, New South Wales, Australia
,
Leonard Kritharides
1   Vascular Biology Group, ANZAC Research Institute, Concord Repatriation General Hospital, University of Sydney, Concord, New South Wales, Australia
3   Department of Cardiology, Concord Repatriation General Hospital, Sydney Local Health District, New South Wales, Australia
› Author Affiliations Funding This work was supported by the Balnaves Foundation and Sydney Medical School with Kick Start Grants (C.R. and G.J.P.), and National Health and Medical Research Council [NHMRC Program grant number 1037903] (L.K.), and NSW Department of Health CV Research Grant to L.K.
› Further Information
Also available at
    Permissions and Reprints

Comment on:

Insights into Release of Interleukin-1β from PlateletsThromb Haemost 2022; 122(04): 475-475
DOI: 10.1055/a-1683-8567

Abstract

Objective Platelets are critical in mediating both rapid responses to injury and the development and progression of coronary disease. Several studies have shown that, after prolonged exposure to agonists, they produce and release inflammatory mediators including interleukin-1β (IL-1β), via the classical pathway (NLRP3 inflammasome and caspase-1 cleavage to release active IL-1β) as described for leukocytes. This study aimed to determine whether there is rapid release of IL-1β in response to soluble platelet agonists and whether such rapid release is NLRP3- and caspase-1-dependent.

Methods and Results Using flow cytometry to detect platelet activation (and release of α and dense granule contents) and the combination of Western blotting, enzyme-linked-immunosorbent assay, and immunogold labeling transmission electron and immunofluorescence microscopy, we identified that resting human platelets contain mature IL-1β. Platelets release IL-1β within minutes in response to adenosine diphosphate (ADP), collagen, and thrombin receptor agonists, but not in response to conventional NLRP3 inflammasome agonists—lipopolysaccharide and adenosine triphosphate. The rapid release of IL-1β in response to ADP and thrombin receptor agonists was independent of caspases (including caspase-1) and NLRP3. Immature and mature IL-1β were identified as low-abundance proteins on transmission electron microscopy of human platelets, and were localized to the platelet cytosol, open canalicular system, and the periphery of α granules.

Conclusion Unlike monocytes and neutrophils, human platelets are capable of rapid agonist- and time-dependent release of IL-1β by a mechanism which is independent of caspase-1 and NLRP3.

Keywords

platelet - inflammation - interleukin-1β - NLRP3 - inflammasome

Supplementary Material



Publication History

Received: 07 December 2020

Accepted: 07 May 2021

Article published online:
25 June 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Lebas H, Yahiaoui K, Martos R, Boulaftali Y. Platelets are at the nexus of vascular diseases. Front Cardiovasc Med 2019; 6: 132
    CrossrefPubMedSearch in Google Scholar
  • 2 Nording HM, Seizer P, Langer HF. Platelets in inflammation and atherogenesis. Front Immunol 2015; 6: 98
    CrossrefPubMedSearch in Google Scholar
  • 3 Badimon L, Padró T, Vilahur G. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur Heart J Acute Cardiovasc Care 2012; 1 (01) 60-74
    CrossrefPubMedSearch in Google Scholar
  • 4 Gros A, Ollivier V, Ho-Tin-Noé B. Platelets in inflammation: regulation of leukocyte activities and vascular repair. Front Immunol 2015; 5: 678
    CrossrefPubMedSearch in Google Scholar
  • 5 Barrett TJ, Schlegel M, Zhou F. et al. Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis. Sci Transl Med 2019; 11 (517) eaax0481
    CrossrefPubMedSearch in Google Scholar
  • 6 Tunjungputri RN, Li Y, de Groot PG. et al. The inter-relationship of platelets with interleukin-1β-mediated inflammation in humans. Thromb Haemost 2018; 118 (12) 2112-2125
    Thieme ConnectPubMedSearch in Google Scholar
  • 7 Massberg S, Brand K, Grüner S. et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002; 196 (07) 887-896
    CrossrefPubMedSearch in Google Scholar
  • 8 Van Tassell BW, Toldo S, Mezzaroma E, Abbate A. Targeting interleukin-1 in heart disease. Circulation 2013; 128 (17) 1910-1923
    CrossrefPubMedSearch in Google Scholar
  • 9 Larsen CM, Faulenbach M, Vaag A. et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007; 356 (15) 1517-1526
    CrossrefPubMedSearch in Google Scholar
  • 10 Kay J, Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 2004; 43 (Suppl. 03) iii2-iii9
    CrossrefPubMedSearch in Google Scholar
  • 11 Ruscitti P, Masedu F, Alvaro S. et al. Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): a multicentre, open-label, randomised controlled trial. PLoS Med 2019; 16 (09) e1002901
    CrossrefPubMedSearch in Google Scholar
  • 12 Ridker PM, Everett BM, Thuren T. et al; CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017; 377 (12) 1119-1131
    CrossrefPubMedSearch in Google Scholar
  • 13 Afonina IS, Müller C, Martin SJ, Beyaert R. Proteolytic processing of interleukin-1 family cytokines: variations on a common theme. Immunity 2015; 42 (06) 991-1004
    CrossrefPubMedSearch in Google Scholar
  • 14 Sheedy FJ, Grebe A, Rayner KJ. et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol 2013; 14 (08) 812-820
    CrossrefPubMedSearch in Google Scholar
  • 15 Lindemann S, Tolley ND, Dixon DA. et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001; 154 (03) 485-490
    CrossrefPubMedSearch in Google Scholar
  • 16 Denis MM, Tolley ND, Bunting M. et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 2005; 122 (03) 379-391
    CrossrefPubMedSearch in Google Scholar
  • 17 Brown GT, McIntyre TM. Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1β-rich microparticles. J Immunol 2011; 186 (09) 5489-5496
    CrossrefPubMedSearch in Google Scholar
  • 18 Brown GT, Narayanan P, Li W, Silverstein RL, McIntyre TM. Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop. J Immunol 2013; 191 (10) 5196-5203
    CrossrefPubMedSearch in Google Scholar
  • 19 Hottz ED, Lopes JF, Freitas C. et al. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood 2013; 122 (20) 3405-3414
    CrossrefPubMedSearch in Google Scholar
  • 20 Murthy P, Durco F, Miller-Ocuin JL. et al. The NLRP3 inflammasome and bruton's tyrosine kinase in platelets co-regulate platelet activation, aggregation, and in vitro thrombus formation. Biochem Biophys Res Commun 2017; 483 (01) 230-236
    CrossrefPubMedSearch in Google Scholar
  • 21 Boilard E, Nigrovic PA, Larabee K. et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010; 327 (5965): 580-583
    CrossrefPubMedSearch in Google Scholar
  • 22 Qiao J, Wu X, Luo Q. et al. NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis. Haematologica 2018; 103 (09) 1568-1576
    CrossrefPubMedSearch in Google Scholar
  • 23 Vats R, Brzoska T, Bennewitz MF. et al. Platelet extracellular vesicles drive inflammasome-il-1β-dependent lung injury in sickle cell disease. Am J Respir Crit Care Med 2020; 201 (01) 33-46
    CrossrefPubMedSearch in Google Scholar
  • 24 Rolfes V, Ribeiro LS, Hawwari I. et al. Platelets fuel the inflammasome activation of innate immune cells. Cell Rep 2020; 31 (06) 107615
    CrossrefPubMedSearch in Google Scholar
  • 25 Bester J, Pretorius E. Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity. Sci Rep 2016; 6: 32188
    CrossrefPubMedSearch in Google Scholar
  • 26 Beaulieu LM, Lin E, Mick E. et al. Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans. Arterioscler Thromb Vasc Biol 2014; 34 (03) 552-564
    CrossrefPubMedSearch in Google Scholar
  • 27 Sheikh S, Rahman M, Gale Z. et al. Differing mechanisms of leukocyte recruitment and sensitivity to conditioning by shear stress for endothelial cells treated with tumour necrosis factor-alpha or interleukin-1beta. Br J Pharmacol 2005; 145 (08) 1052-1061
    CrossrefPubMedSearch in Google Scholar
  • 28 Rider P, Carmi Y, Guttman O. et al. IL-1α and IL-1β recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol 2011; 187 (09) 4835-4843
    CrossrefPubMedSearch in Google Scholar
  • 29 Pennings GJ, Yong AS, Kritharides L. Expression of EMMPRIN (CD147) on circulating platelets in vivo. J Thromb Haemost 2010; 8 (03) 472-481
    CrossrefPubMedSearch in Google Scholar
  • 30 Reddel CJ, Pennings GJ, Curnow JL, Chen VM, Kritharides L. Procoagulant effects of low-level platelet activation and its inhibition by colchicine. Thromb Haemost 2018; 118 (04) 723-733
    PubMedSearch in Google Scholar
  • 31 Yamashita S. The post-embedding method for immunoelectron microscopy of mammalian tissues: a standardized procedure based on heat-induced antigen retrieval. Methods Mol Biol 2010; 657: 237-248
    CrossrefPubMedSearch in Google Scholar
  • 32 Reynolds ES. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 1963; 17: 208-212
    CrossrefPubMedSearch in Google Scholar
  • 33 Sedlmayr P, Blaschitz A, Wilders-Truschnig M, Tiran A, Dohr G. Platelets contain interleukin-1 alpha and beta which are detectable on the cell surface after activation. Scand J Immunol 1995; 42 (02) 209-214
    CrossrefPubMedSearch in Google Scholar
  • 34 Hawrylowicz CM, Santoro SA, Platt FM, Unanue ER. Activated platelets express IL-1 activity. J Immunol 1989; 143 (12) 4015-4018
    CrossrefPubMedSearch in Google Scholar
  • 35 Pillitteri D, Bassus S, Boller K. et al. Thrombin-induced interleukin 1β synthesis in platelet suspensions: impact of contaminating leukocytes. Platelets 2007; 18 (02) 119-127
    CrossrefPubMedSearch in Google Scholar
  • 36 Dinarello CA. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med 2000; 343 (10) 732-734
    CrossrefPubMedSearch in Google Scholar
  • 37 Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011; 117 (14) 3720-3732
    CrossrefPubMedSearch in Google Scholar
  • 38 Hottz ED, Medeiros-de-Moraes IM, Vieira-de-Abreu A. et al. Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue. J Immunol 2014; 193 (04) 1864-1872
    CrossrefPubMedSearch in Google Scholar
  • 39 Linke B, Schreiber Y, Picard-Willems B. et al. Activated platelets induce an anti-inflammatory response of monocytes/macrophages through cross-regulation of pge2 and cytokines. Mediators Inflamm 2017; 2017: 1463216
    CrossrefPubMedSearch in Google Scholar
  • 40 Nhek S, Clancy R, Lee KA. et al. Activated platelets induce endothelial cell activation via an interleukin-1β pathway in systemic lupus erythematosus. Arterioscler Thromb Vasc Biol 2017; 37 (04) 707-716
    CrossrefPubMedSearch in Google Scholar
  • 41 Skaria T, Bachli E, Schoedon G. RSPO3 impairs barrier function of human vascular endothelial monolayers and synergizes with pro-inflammatory IL-1. Mol Med 2018; 24 (01) 45
    CrossrefPubMedSearch in Google Scholar
  • 42 Argaw AT, Zhang Y, Snyder BJ. et al. IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol 2006; 177 (08) 5574-5584
    CrossrefPubMedSearch in Google Scholar
  • 43 Xiong S, Hong Z, Huang LS. et al. IL-1β suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury. J Clin Invest 2020; 130 (07) 3684-3698
    CrossrefPubMedSearch in Google Scholar